REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,000 | -50.0% | 1,000 | -66.7% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $109,000 | 0.05% |
| CONDOR CAPITAL MANAGEMENT | 211,371 | $154,000 | 0.04% |
| Benin Management CORP | 83,000 | $61,000 | 0.03% |
| First Heartland Consultants, Inc. | 20,000 | $15,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $16,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $131,000 | 0.00% |
| Moors & Cabot, Inc. | 11,000 | $7,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 3,000 | $2,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
| WFG Advisors, LP | 3,500 | $3,000 | 0.00% |